再鼎醫藥(09688.HK)擬5月10日舉行董事會會議 審批一季度業績
格隆匯4月27日丨 再鼎醫藥(09688.HK)公吿,董事會審核委員會將於2023年5月10日(星期三,香港時間)審議及批准(其中包括)根據美國公認會計准則及美國證券交易委員會的適用規則編制的截至2023年3月31日止3個月的未經審核季度業績("第一季度業績")及其發佈。倘獲批准,公司將於2023年5月10日(星期三,香港時間)在香港聯交所網站www.hkexnews.hk及公司網站www.zailaboratory.com發佈第一季度業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.